Clinical Oncology
Clinical Oncology (Clin. Oncol.) is an oncology journal published by Elsevier on behalf of the Royal College of Radiologists and serves as the college's official journal. Founded in September 1989, it concentrates on the clinical management of cancer, radiotherapy and radiobiology, appears ten times a year, and had a 2025 impact factor of 2.5.《临床肿瘤学》（Clinical Oncology''''，缩写 Clin. Oncol.''）是爱思唯尔代表英国皇家放射学会出版的肿瘤学刊物，1989 年 9 月创刊，为该学会会刊。该刊以癌症的临床管理、放射治疗与放射生物学为主，现为每年十期，二〇二五年影响因子为 2.5。
Scope
The journal's editorial stance is that a paper must serve the daily decisions of the clinical oncologist: however sound the methods, it has to bear directly on the investigation, treatment, follow-up or training of cancer care. Coverage runs across the whole clinical chain and concentrates on:本刊的取稿立场是「服务临床肿瘤科医师的日常决策」：一篇论文不论研究方法多么规范，都要能对癌症患者的检查、治疗、随访或培训产生直接影响。收文覆盖肿瘤临床的全链条，重点包括：
- Clinical management of cancer: care pathways by tumour site, multidisciplinary decision-making, assessment of efficacy and toxicity, and follow-up and survivorship care.癌症临床管理： 各部位肿瘤的诊疗路径、多学科团队决策、疗效与毒性评价、随访与生存者照护。
- Radiotherapy and systemic therapy: external beam and brachytherapy, chemoradiation, clinical use of targeted and immunotherapy, and dose fractionation and normal tissue sparing.放射治疗与系统治疗： 外照射与近距离治疗、放化疗联合、靶向与免疫治疗的临床应用、剂量分割与正常组织保护。
- Radiobiology and radiation physics: radiobiological modelling, dosimetry and treatment planning, image guidance and adaptive radiotherapy, and proton and heavy ion therapy.放射生物学与放射物理： 放射生物学模型、剂量学与计划设计、图像引导与自适应放疗、质子与重离子治疗。
- Palliative and supportive care: symptom control and quality of life, end-of-life care, psychosocial support, and palliative radiotherapy.姑息与支持治疗： 症状控制与生活质量、终末期照护、心理社会支持、姑息放疗。
- Tumour biology and immunology: mechanisms of tumour initiation and progression, the tumour immune microenvironment, and clinical translation of biomarkers and molecular typing.肿瘤生物学与免疫学： 肿瘤发生与演进机制、肿瘤免疫微环境、生物标志物与分子分型的临床转化。
- Epidemiology and education: cancer epidemiology and screening, health services and outcomes research, specialist training and continuing education, and guidelines and audit.流行病学与教育培训： 肿瘤流行病学与筛查、卫生服务与结局研究、专科培训与继续教育、指南与审计。
The journal is hybrid with gold open access available and an article processing charge of 3,200 US dollars. The publisher reports seven days to first decision, sixty-five days to a decision after review and 100 days to acceptance, the first-decision figure including editorial screening. No acceptance rate is published, though an editorial from the editor-in-chief states that the desk rejection rate is about 65 per cent.本刊为混合出版，支持金色开放获取，文章处理费为三千二百美元；出版方公布投稿至首次决定七天、复审后决定六十五天、投稿至接收一百天，其中首次决定包含编辑部初筛；录用比例未公布，但主编社论另称编辑部直接退稿比例约为百分之六十五。[1]
History
- Founding (1989): volume 1, issue 1 appeared in September 1989 as the official journal of the Royal College of Radiologists. The journal has used its present name since founding, with no predecessor title and no renaming.创刊（1989年）： 1989 年 9 月出版第 1 卷第 1 期，创刊即为英国皇家放射学会会刊，创刊即用现名，无前身刊名亦无改名。[2]
- Publisher: the journal was published early on by Springer International, moved to W.B. Saunders from 2003 and now sits within the Elsevier portfolio. The year in which the college began working with the publisher is not stated officially.出版方沿革： 本刊早期由（Springer International）出版，2003 年起转由（W.B. Saunders）出版，现归入爱思唯尔期刊体系；学会与出版方的合作起始年份官方未予公布。
- Frequency and format: the journal has appeared ten times a year since 2006. The print arrangement was adjusted in August 2024 and the journal also publishes online ahead of print.刊期与出版形态： 本刊自 2006 年起为每年十期；2024 年 8 月印刷版编排有所调整，本刊同时支持在线优先出版。
- Metrics and indexing: the impact factor is 2.5 and the CiteScore 5.1. The journal is indexed in the Science Citation Index Expanded, Scopus and MEDLINE.指标与收录： 影响因子 2.5、引用分数 5.1；本刊被科学引文索引扩展版、Scopus 与 MEDLINE 收录。[1]
Editors
The editorship is held by British clinical oncologists. The present editor is the sixth incumbent and comes from Cambridge University Hospitals本刊主编由英国临床肿瘤科医师担任，现任主编为第六任，来自剑桥大学医院；历任主编中可考者自 1999 年起，更早的首任主编出版方未予列出。 the traceable succession begins in 1999 and the publisher does not list the founding editor.[3]
- Present editor-in-chief: Thankamma V. Ajithkumar of Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge took up the post in 2022 as the journal's sixth editor.现任主编： （Thankamma V. Ajithkumar）供职于剑桥大学医院国民保健署基金会信托与剑桥大学，2022 年就任，为该刊第六任主编。
- Past editors: Bill Jones stood down in 1999历任主编： （Bill Jones）于 1999 年卸任；（Peter Hoskin）1999 年至 2015 年在任；（Charlotte Coles）供职于剑桥，2015 年至 2021 年在任；（Ananya Choudhury）供职于曼彻斯特，2021 年至 2022 年在任；1999 年之前的人选出版方未公布。 Peter Hoskin served from 1999 to 2015 Charlotte Coles, based in Cambridge, from 2015 to 2021 and Ananya Choudhury, based in Manchester, from 2021 to 2022. The incumbents before 1999 are not published.[4]
- Role in the field: as the official journal of the Royal College of Radiologists, the journal carries the college's guidelines, audit results and training matters, and its readership is mainly clinical oncologists in the United Kingdom and Commonwealth systems.学科角色： 作为英国皇家放射学会会刊，本刊承担英国临床肿瘤学的指南发布、审计结果与培训议题的发表职能，其读者以英国及英联邦体系的肿瘤科医师为主。[5]